CLINICAL_TRIALS
trial_result
· 2025-10-03
Clinical Trial Update: Study of a Novel Antipsychotic ITI-007 in Schizophrenia [Phase 2]
Summary
Phase 2 clinical trial update for ITI-007 (lumateperone) in schizophrenia; the study is completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Intra-Cellular Therapies, Inc. | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2025-10-03